Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $122.2 million.

  • Ironwood Pharmaceuticals' Non-Current Assets fell 4205.3% to $122.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $608.6 million, marking a year-over-year decrease of 3213.69%. This contributed to the annual value of $168.5 million for FY2024, which is 2912.08% down from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Non-Current Assets is $122.2 million, which was down 4205.3% from $151.2 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Non-Current Assets ranged from a high of $387.0 million in Q2 2021 and a low of $61.1 million during Q1 2021
  • Over the past 5 years, Ironwood Pharmaceuticals' median Non-Current Assets value was $270.5 million (recorded in 2023), while the average stood at $260.9 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 55076.52% in 2021, then tumbled by 4205.3% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Non-Current Assets (Quarter) stood at $381.7 million in 2021, then fell by 16.19% to $319.9 million in 2022, then fell by 25.67% to $237.8 million in 2023, then dropped by 29.12% to $168.5 million in 2024, then fell by 27.48% to $122.2 million in 2025.
  • Its Non-Current Assets was $122.2 million in Q3 2025, compared to $151.2 million in Q2 2025 and $166.6 million in Q1 2025.